New York-Based Marijuana Company, Acreage, Sees YoY Revenue Decline, But Also Lower Net Loss

Zinger Key Points
  • Acreage Holdings reported fourth-quarter revenue of $52.8 million, compared to $57.5 million in the same period the year before.  
Loading...
Loading...

Multi-state cannabis operator, Acreage Holdings, Inc. ACRG ACRHF, reported its financial results Monday for the fourth quarter and full year ended December 31, 2023. The earnings report revealed quarterly revenue of $52.8 millioncompared to $57.5 million in the same period of the prior year, while yearly revenue reached $223.4 million, versus $237.1 million in the full year 2022.

"Throughout 2023, we completed various strategic initiatives that have positioned us strongly ahead of our acquisition by Canopy USA," stated Dennis Curran, chief executive officer of Acreage. "During the quarter, we completed the anticipated expansion of our Egg Harbor, New Jersey facility, bolstering these operations with more canopy and manufacturing equipment to increase the output of in-demand, high-margin products such as edibles and concentrates. We also upgraded our cultivation capabilities in Freeport, Illinois, where we produce non-remediated flower, a unique and top-selling offering to the market”.  

Curran continued, "Our flagship brands continue to perform exceptionally well, particularly in new states where they have recently made their debut, such as New Jersey for Superflux and New York and Pennsylvania for The Botanist. This has prompted us to optimize our portfolio and focus on expanding distribution of our most successful products and brands that will cohesively fit into Canopy USA’s ecosystem alongside Wana and Jetty."

See Also: Canopy Is ‘Cautiously Optimistic’ On Cannabis Rescheduling Following Major Step Toward Entry Into US THC Market

Q4 Earnings Highlights 

  • Gross margin was 32%, which compares to 35% in the same period of the prior year. 
  • Gross profit was $16.66 million, versus $20.4 million in the fourth quarter of 2022.
  • Net loss was $35.7 million, compared to net loss of $119.18 million in the corresponding period of 2022.  
  • Adjusted EBITDA reached $4.3 million, versus $6.99 million in the fourth quarter of 2022.

Grow your cannabis business and raise capital at Benzinga’s New Jersey Market Spotlight on June 17. Network with key industry players, hear from the top operators and close deals that will shape the future. Act now— spots are filling fast. Get your tickets here.

Full Year 2023 Financial Summary

  • Adjusted EBITDA was $28.3 million compared to $34.8 million in full year 2022.  
  • Net loss amounted to $77.96, which compares to a net loss of $168.7 million in the previous fiscal year. 
  • Gross profit reached $85.65 million, versus $101.75 million for full 2022. 

Price Action

Acreage shares closed Monday market session 8.83% lower at 29 cents per share.  

Now Read: New York Gov Hochul Orders Review Of Cannabis Licensing Process After Numerous Setbacks

Photo: Courtesy of YARphotographer via Shutterstock

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsCannabis EarningsDennis Curran
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...